All In Biotech

Free tool

FAERS Monitor: Adasuve

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022549 or its brand name (Adasuve, Loxapine). Reports on generic versions are filed under their own applications.

Reports

3,993

Serious

3,781

95% of reports

Hospitalization

2,117

Death reported

626

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective322
  • coma274
  • somnolence262
  • toxicity to various agents233
  • drug interaction225
  • weight increased219
  • poisoning deliberate215
  • off label use202
  • suicide attempt185
  • akathisia166
  • death163
  • neuroleptic malignant syndrome159
  • drug abuse154
  • product use in unapproved indication150
  • tachycardia143

Reports by year received

View as table
YearReports
200412
200513
200627
200726
200826
200920
201039
201154
201241
201335
201442
201581
201680
2017132
2018168
2019232
2020231
2021276
2022480
2023530
2024577
2025483
2026388

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,166 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
poisoning deliberateSignal215122.2107.125,153
neuroleptic malignant syndromeSignal15971.661.410,851
akathisiaSignal16664.955.810,254
comaSignal27430.527.27,756
suicide attemptSignal18516.114.02,608
drug abuseSignal1549.88.41,205
tachycardiaSignal1438.57.2940
drug interactionSignal2257.56.61,264
toxicity to various agentsSignal2337.36.41,266
somnolenceSignal2626.96.11,317
weight increasedSignal2195.24.5736
product use in unapproved indicationSignal1503.22.7226
drug ineffective3221.31.222
off label use2021.21.18
death1631.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.